Insider Trading History of Jorden David Emerson

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Jorden David Emerson since 2016. This trader's CIK number is 1313516. At the time of last reporting, Jorden David Emerson was the CEO/CFO of Nuo Therapeutics, Inc.. (stock ticker symbol AURX). Also see all insider trading activities at Nuo Therapeutics, Inc..

Note that in the past JORDEN DAVID EMERSON also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Plx Pharma Inc. (PLXP) by Jorden David Emerson

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 PLXP 32,727 $224,998 0 $0 0 $0

Yearly summary of insider trading at Nuo Therapeutics, Inc. (AURX) by Jorden David Emerson

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 AURX 0 $0 0 $0 192,710 $77,084
2022 AURX 0 $0 325,000 $487,500 0 $0
2017 AURX 247,500 $54,945 0 $0 0 $0
2016 AURX 137,500 $137,500 0 $0 0 $0


Insider trading activities at 2 companies by Jorden David Emerson:

1. Plx Pharma Inc. (PLXP)

2. Nuo Therapeutics, Inc. (AURX)

Table 1. Insider trading of Plx Pharma Inc. (PLXP) by Jorden David Emerson

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-06-14 PLXP Buy 32,727 6.88 224,998

Table 2. Insider trading of Nuo Therapeutics, Inc. (AURX) by Jorden David Emerson

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-01 AURX Option Ex 192,710 .40 77,084
2022-11-09 AURX Sale 162,500 1.50 243,750
2022-11-09 AURX Sale 162,500 1.50 243,750
2017-08-10 AURX Buy 247,500 .22 54,945
2016-05-05 NONE Buy 137,500 1.00 137,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jorden David Emerson (CEO/CFO of Nuo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.